Skip to content
montabiosciences.commontabiosciences.com
  • Home
  • About us
    • Company History
    • Management
    • Board of Directors
    • Founders
  • Technology
    • Todays Challenges
    • Cancer Treatment
    • Cancer Immunotherapy
    • Development
    • References
  • News
  • Contact us
News

Meeting with Key Opinion Leaders to plan phase I trial in patients

MonTa Biosciences attends the ESMO conference in Barcelona to meet with Key Opinion Leaders to plan phase I trial in patients

Fireside interview at the IP-FAIR conference
Presenting data at the cancer immunotherapy SITC conference

MonTa Biosciences ApS

Diplomvej 381
2800 Kgs. Lyngby
Denmark

VAT nr. 36697016




    By contacting us, you agree to our privacy statement.

    Privacy statement
    MonTa Biosciences - Cancer Therapeutics of Tomorrow
    • Home
    • About us
      • Company History
      • Management
      • Board of Directors
      • Founders
    • Technology
      • Todays Challenges
      • Cancer Treatment
      • Cancer Immunotherapy
      • Development
      • References
    • News
    • Contact us